# Tofacitinib Ameliorates Lipopolysaccharide‐Induced Acute Kidney Injury by Blocking the JAK‐STAT1/STAT3 Signaling Pathway

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tofacitinib-ameliorates-lipopolysaccharide-induced-acute-kidney-injury-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yun Yang,Jingyu Chen,Xuejiao Wang,Yingzhuo Li,Zhifan Hu,Pingting Yang,Ling Qin |
| Citations | 31 |
| DOI | 10.1155/2021/8877056 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://downloads.hindawi.com/journals/bmri/2021/8877056.pdf |
| OpenAlex ID | https://openalex.org/W3119499893 |
| PMID | 33511217 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Pingting Yang](https://scholariq.org/researchers/pingting-yang/)

## Paper journal

- [BioMed Research International](https://scholariq.org/journals/biomed-research-international/)

## Paper primary topic

- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Paper topics

- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Drug-Induced Hepatotoxicity and Protection](https://scholariq.org/topics/drug-induced-hepatotoxicity-and-protection/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.